Page last updated: 2024-10-29

ketanserin and Hypermyotonia

ketanserin has been researched along with Hypermyotonia in 1 studies

Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhao, A1
Urban, JF1
Morimoto, M1
Elfrey, JE1
Madden, KB1
Finkelman, FD1
Shea-Donohue, T1

Other Studies

1 other study available for ketanserin and Hypermyotonia

ArticleYear
Contribution of 5-HT2A receptor in nematode infection-induced murine intestinal smooth muscle hypercontractility.
    Gastroenterology, 2006, Volume: 131, Issue:2

    Topics: Animals; Disease Models, Animal; Female; Gene Expression; Ketanserin; Mice; Mice, Inbred BALB C; Mus

2006